Intangible Assets

CVKD shows no evident brand, patent, or regulatory-intangible advantage in the provided filings-based metrics, so it lacks a durable pricing-power edge versus peers.

The absence of positive ROIC and the negative TTM ROIC imply the company is not monetizing any proprietary asset base better than peers, which weakens evidence of intangible differentiation.

No disclosed evidence of exclusive IP, clinical data exclusivity, or protected know-how was provided, so any intangible moat appears limited and replicable relative to peers.

Switching Costs

The negative TTM ROIC and lack of sustained profitability indicate customers are not locked in by meaningful switching frictions that preserve margins versus peers.

No filing evidence was provided of contractual lock-in, workflow integration, or embedded usage that would make replacement costly for customers.

Compared with peers that benefit from recurring contracts or integrated platforms, CVKD appears to have little observable retention advantage from switching costs.

Network Effects

The provided data do not show user, data, or ecosystem compounding that would make the business more valuable as adoption rises.

Negative returns and no evidence of platform-scale usage suggest CVKD is not operating a peer-dependent network model.

Relative to peers with marketplace or data-network flywheels, CVKD shows no visible network-effect moat.

Cost Advantage

A negative ROIC and no margin history in the provided metrics do not support a structural cost advantage over peers.

The extreme negative cash conversion cycle figure is not evidence of durable unit-cost superiority and instead suggests the metrics are not showing a stable operating advantage.

Without disclosed scale procurement, manufacturing, or process efficiencies, CVKD does not appear to have a repeatable cost edge versus peers.

Efficient Scale

The available information does not indicate that CVKD serves a niche market with natural monopoly economics or that peers are constrained from entering its core market.

Negative profitability suggests the company has not yet reached a scale position that protects margins through industry capacity limits.

Compared with established peers that can defend share through scale economics, CVKD shows no clear evidence of efficient-scale protection.

Overall Score

CVKD appears to have a weak and non-durable moat versus peers because the provided evidence shows negative capital returns and no disclosed structural advantages in intangible assets, switching costs, network effects, cost advantage, or efficient scale.